KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

KORU Medical Systems, Inc.NASDAQ: KRMD

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense remains negative

Q1 FY2026 income tax expense was $0, compared with $0 a year earlier. Trailing-twelve-month income tax expense was $21.89K.

Context

  • Income tax expense amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $5.47K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$21.89K+656.7% YoY
LTMMar 2026
$21.89K+656.7% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+656.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
21.89K USD
Year-over-year change
+656.7%

Income Tax Expense vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +656.7% is the highest of 8, against a peer median of +13.3%.
  • Income tax expense amounts to 0.1% of revenue for KRMD, versus a peer median of 1.3%.
KRMD Competitors
Income Tax Expense for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INFUInfuSystem Holdings, Inc.LTM Mar 2026$3.88M USD+13.3%+229.2%2.7%
UTMDUtah Medical Products, Inc.LTM Mar 2026$2.58M USD-11.0%-12.3%6.9%
OSUROraSure Technologies, Inc.LTM Mar 2026$1.83M USD+34.1%+7.3%1.6%
NYXHNyxoah S.A.LTM Mar 2026€1.33M EUR-52.7%-4.8%8.2%
PROFProfound Medical Corp.LTM Mar 2026$237.15K USD+652.3%-3.7%1.3%
PREPrenetics Global LimitedLTM Mar 2026$47K USD+100.6%—0.0%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$21.89K USD+656.7%—0.1%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$6K USD-25.0%-8.0%0.0%
MXCTMaxCyte, Inc.LTM Mar 2026$0 USD——0.0%
STIMNeuronetics, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding KRMD) —+13.3%-4.2%1.3%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.